Free Trial

Repare Therapeutics (RPTX) SEC Filings & 10K Form

Repare Therapeutics logo
$3.35
-0.10 (-2.90%)
(As of 10/31/2024 ET)

Recent Repare Therapeutics SEC Filings

DateFilerForm TypeView
08/19/2024
11:15 PM
Repare Therapeutics (Filer)
Form EFFECT
08/07/2024
8:06 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:41 PM
Repare Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/06/2024
3:20 PM
Repare Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/20/2024
3:27 PM
Repare Therapeutics (Issuer)
Stein Steven H (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2024
3:36 PM
Repare Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Repare Therapeutics (Issuer)
Stein Steven H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Civik Thomas (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Bonita David P (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Kulkarni Samarth (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Molineaux Susan (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Morrison Briggs (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Repare Therapeutics (Issuer)
RHOADS ANN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
3:06 PM
Repare Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/26/2024
3:14 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
8:27 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
8:28 PM
Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
8:30 PM
Forte Steve (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
8:31 PM
Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:54 PM
Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:56 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:57 PM
Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:59 PM
Forte Steve (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
11:37 AM
Forte Steve (Reporting)
Repare Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
1:50 PM
Repare Therapeutics (Subject)
Segal Lloyd Mitchell (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
6:25 PM
Repare Therapeutics (Subject)
Segal Lloyd Mitchell (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:23 PM
Koehler Maria (Reporting)
Repare Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:23 PM
Repare Therapeutics (Subject)
Zinda Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
8:02 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
8:04 PM
Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
8:06 PM
Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:10 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:15 AM
Repare Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
8:02 PM
Blue Owl Capital Holdings LP (Filed by)
Repare Therapeutics (Subject)
Form SC 13G
02/14/2024
7:54 AM
Deep Track Capital, LP (Filed by)
Repare Therapeutics (Subject)
Form SC 13G/A
01/29/2024
3:01 PM
ARK Investment Management LLC (Filed by)
Repare Therapeutics (Subject)
Form SC 13G/A
01/25/2024
1:29 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
3:05 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
3:19 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
3:52 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Repare Therapeutics (Subject)
Form SC 13D/A
11/17/2023
3:54 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
The most productive 1 min of your day… (Ad)

This next step in your trading career is a simple, yet important one. I want you to take 1 minute to sign up for FREE algo alerts powered by StocksToTrade.

>> Click Here To Sign Up For StocksToTrade’s Algo Alerts <<
11/15/2023
6:20 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:05 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:10 AM
Repare Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2023
4:20 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Repare Therapeutics (Subject)
Form SC 13D
11/03/2023
4:37 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RPTX) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners